Carbonic anhydrase inhibitors and altitude sickness

At altitude, lower air pressure reduces the oxygen available with each breath. A carbonic anhydrase inhibitor changes how the kidneys handle bicarbonate and can encourage deeper breathing, supporting acclimatisation. It is commonly discussed for acute mountain sickness, which may involve headache, nausea, dizziness, tiredness, or poor sleep. The medicine does not make high altitude safe and does not treat dangerous altitude illness by itself.

Discuss the medicine before travel, including allergies, kidney or liver problems, pregnancy, breastfeeding, and other medicines. Follow the prescribed dose and timing; do not borrow tablets or alter the plan because a travel partner feels unwell. Ascend gradually, allow time to acclimatise, drink normally, avoid alcohol, and do not continue climbing when symptoms are worsening. A travel health consultation can help you plan prevention, recognise symptoms, and prepare an ascent and descent strategy.

Stop ascending and seek medical advice for persistent or worsening headache, repeated vomiting, unusual confusion, poor coordination, breathlessness at rest, a cough producing frothy sputum, or difficulty walking. Descend promptly if symptoms suggest serious altitude illness, using assistance if needed. Emergency help is required for severe breathing difficulty, collapse, seizures, or reduced alertness. Do not wait for the medicine to take effect when red flags appear.

Ask whether this medicine suits your health history, when to start and stop it, which side effects matter, and what to do if you miss a dose. Ask how your itinerary, sleeping altitude, previous altitude symptoms, and access to descent should change the plan.